However, the inhibition of BChE is considered a potential therapeutic target to restore the levels of ACh in the brain, improving cognitive deterioration and reducing the adverse effects in patients with Alzheimer’s disease. The gene discussed is BCHE; the disease is early-onset autosomal dominant Alzheimer disease.